Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Novavax Inc
(NQ:
NVAX
)
127.43
USD
-2.55 (-1.96%)
Official Closing Price
Updated: 7:59 PM EST, Jan 15, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Novavax Inc
< Previous
1
2
3
4
5
6
7
8
9
...
70
71
Next >
World Bank Approves $12B Financing To Ensure Developing Countries Aren't Deprived Of COVID-19 Vaccine
October 14, 2020
The World Bank said Monday that its Board of Executive Directors has approved$12 billion in financing for developing countries to ...
Tags
Vaccines
MRNA
Financing
From
Benzinga
Novavax To Evaluate Flu-COVID-19 Vaccine Combo
October 13, 2020
Novavax, Inc. (NASDAQ: NVAX) shares were advancing strongly Tuesday after the coronavirus vaccine developer announced updates on its ...
Tags
General
Movers
Biotech
From
Benzinga
46 Stocks Moving In Tuesday's Mid-Day Session
October 13, 2020
Gainers Medigus Ltd. (NASDAQ: MDGS) shares climbed 57.2% to $2.97 after the company announced it was informed by Smart Repair Pro ...
Tags
FTHM
IEA
HUSN
From
Benzinga
Novavax Sets Up Team To Explore A Combination Covid-19/Flu Vaccine Post-Pandemic
October 13, 2020
Novavax on Tuesday named a team of executives to lead the exploration of a possible Covid-19/flu combo vaccine, for after the pandemic, as it continues late-stage trials on its Covid vaccine.
From
Investor's Business Daily
Are These The Best Biotech Stocks To Watch This Week?
October 13, 2020
From
Stockmarket.com
Johnson & Johnson Pauses Covid-19 Vaccine Tests; Raises Earnings Guidance
October 13, 2020
Johnson & Johnson paused key final-phase testing of its Covid-19 vaccine candidate, but then beat third-quarter earnings views. JNJ stock fell.
From
Investor's Business Daily
How The Parts Add Up: XBI Headed For $174
October 13, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Is Novavax Stock Too Risky to Buy Today?
October 12, 2020
The stock has soared by 2,700% so far this year. Is it still worth investing in today?
Tags
JNJ
NVAX
Market News
From
Motley Fool
Why Is Everyone Talking About Inovio Stock?
October 12, 2020
This popular coronavirus vaccine developer stock is down 61% from all-time highs, and the bottom has yet to arrive.
Tags
CVAC
JNJ
NVAX
From
Motley Fool
3 Stocks to Buy No Matter What Happens in November
October 11, 2020
Forget politics and a pandemic. The outlook for these stocks keeps getting better, and analysts can't keep up.
Tags
Market News
VXRT
EBS
From
Motley Fool
Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?
October 10, 2020
Much still rests on the fate of Inovio's halted coronavirus vaccine trial.
Tags
NVAX
Market News
INO
From
Motley Fool
Better Coronavirus Stock: Johnson & Johnson vs. Novavax
October 10, 2020
These COVID-19 vaccine leaders offer very different risk-reward propositions.
Tags
JNJ
NVAX
Market News
From
Motley Fool
Notable Friday Option Activity: NVAX, MS, MDC
October 09, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Novavax, Inc. (NVAX), where a total volume of 19,501 contracts has been traded thus...
Tags
Stocks
From
Market News Video
Are These The Top Medical Stocks To Watch In 2020?
October 09, 2020
From
Stockmarket.com
2 Healthcare Stocks That Could Soar in 2020
October 08, 2020
But are they likely to outperform in the long run?
Tags
Market News
NVAX
VXRT
From
Motley Fool
3 Popular Robinhood Stocks That Could Realistically Double Within 1 Year
October 08, 2020
Here's what it would take.
Tags
CGC
IBIO
Market News
From
Motley Fool
Moderna, Pfizer Have 2-Month Lead Over Coronavirus Vaccine Competitors: Analyst
October 07, 2020
The coronavirus vaccine race hastwo likely winners that have surged ahead in a crowded field, according to an SVB Leerink ...
Tags
Analyst Ratings
Analyst Color
SVB Leerink
From
Benzinga
Bill Gates Says Regulatory Approval For Antibody Drugs Could Sharply Reduce COVID-19 Mortality
October 07, 2020
Antibody drugs currently undergoing testing could be a panacea for the COVID-19 pandemic ravaging the world once they get regulatory ...
Tags
Benzinga
U/S/ Centers for Disease Control and Prevention
JNJ
From
Benzinga
COVID-19 Vaccine Developer Novavax In Spotlight As Insiders Offload Shares
October 06, 2020
Novavax, Inc. (NASDAQ: NVAX) shares, which peaked at $189.40 in early August, gave back some of their gains through August and early ...
Tags
Benzinga
Biotech
TAK
From
Benzinga
Pfizer, BioNTech Start Approval Process For Covid-19 Vaccine Candidate In Europe
October 06, 2020
BioNTech and partner Pfizer announced the start of a rolling submission process for the approval of their Covid-19 vaccine candidate in Europe.
From
Investor's Business Daily
Pfizer, BioNTech Start Approval Process For Covid-19 Vaccine Candidate In Europe
October 06, 2020
BioNTech and partner Pfizer announced the start of a rolling submission process for the approval of their Covid-19 vaccine candidate in Europe.
From
Investor's Business Daily
Pfizer, BioNTech Start Approval Process For Covid-19 Vaccine Candidate In Europe
October 06, 2020
BioNTech and partner Pfizer announced the start of a rolling submission process for the approval of their Covid-19 vaccine candidate in Europe.
From
Investor's Business Daily
Why Is Everyone Talking About Novavax Stock?
October 06, 2020
The vaccine specialist is squarely in the COVID-19 discussion.
Tags
Market News
NVAX
BNTX
From
Motley Fool
COVID-19 Vaccine Makers AstraZeneca, GSK To Get First Access To Nvidia's 'Cambridge-1' Supercomputer
October 06, 2020
Nvidia Corporation (NASDAQ: NVDA) said Monday it is working to build the United Kingdom’s most powerful supercomputer, which it ...
Tags
Cambridge/1
NVDA
General
From
Benzinga
Doubling Down On China's COVID-19 Bio-Tech Disrupters
October 05, 2020
Looking for Alpha Undervalued Bio-Tech COVID-19 Disrupters.
Tags
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
Are These The Best Biotech Stocks To Buy Right Now? 3 Names To Watch
October 05, 2020
From
Stockmarket.com
Should You Buy Biotech or Big Pharma in the COVID-19 Vaccine Race?
October 04, 2020
One offers massive potential for gains. The other offers security.
Tags
AZN
MRNA
NVAX
From
Motley Fool
Will Big Pharma Acquire Novavax?
October 03, 2020
The value of this vaccine specialist has shifted dramatically because of the coronavirus.
Tags
SNY
RHHBY
NVS
From
Motley Fool
Notable ETF Inflow Detected - PTH, NVAX, WST, TDOC
October 02, 2020
Symbols mentioned in this story: PTH, NVAX, WST, TDOC Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Got $5,000? 3 Stocks to Buy That Could Double by 2022
October 02, 2020
Here's how they could do it.
Tags
CRLBF
IIPR
NVAX
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
70
71
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.